    Charles Harwood | INC Research , Inc. | ZoomInfo.com










 













 




Charles C  Harwood Jr - CEO, founder, businessman - profile

















directorpedia.net - List of CEOs, founders, board members and company directors











Charles C  Harwood Jr
Check out list of companies and businesses related to Charles C  Harwood Jr. Find out Charles C  Harwood Jr address and contact details. View other people related to Charles C  Harwood Jr - coworkers, colleagues, companions, etc.
Address:   

C/O INC RESEARCH HOLDINGS, INC. 3201 BEECHLEAF COURT, SUITE 600 RALEIGH 27604 NC




Companies related to Charles C  Harwood Jr
CIKCompany NamePositionCompany Address0001610950INC Research Holdings, Inc.Director 3201 BEECHLEAF COURT SUITE 600 RALEIGH 276040001661181Avista Healthcare Public Acquisition Corp. 65 EAST 55TH STREET 18TH FLOOR NEW YORK 10022




Charles C  Harwood Jr on the Web
Persons related to Charles C  Harwood Jr - INC Research Holdings, Inc.NamePositionCity1829356 Ontario LtdTORONTOACP INC Research Co-Invest, LLCRALEIGHAvista Capital Partners II GP, LLC10% Owner NEW YORKAvista Capital Partners II GP, LLCRALEIGHAvista Capital Partners II, L.P.NEW YORKAvista Capital Partners II, L.P.RALEIGHAvista Capital Partners (Offshore) II-A, LPNEW YORKAvista Capital Partners (Offshore) II-A, LPRALEIGHAvista Capital Partners (Offshore) II, L.P.NEW YORKAvista Capital Partners (Offshore) II, L.P.RALEIGHJAMES A  BANNONRALEIGHRobert W  BreckonDirector TORONTO, ONTARIO, CANADARobert W  BreckonRALEIGHDavid F  BurgstahlerDirector NEW YORKDavid F  BurgstahlerRALEIGHSteve  FaraoneRALEIGHChristopher L  GaenzleCAO, GC & Sec RALEIGHMichael  GibertiniChief Operating Officer RALEIGHLinda S  HartyDirector DUBLINCharles C  Harwood JrDirector RALEIGHINC Research Mezzanine Co-Invest, LLCRALEIGHRichard N  KenderDirector WHITEHOUSE STATIONRichard N  KenderRALEIGHWILLIAM E  KLITGAARDDirector PRINCETONAlistair  MacdonaldChief Executive Officer RALEIGHD. Jamie  MacdonaldChief Executive Officer CINCINNATID. Jamie  MacdonaldRALEIGHKenneth F  MeyersDirector LAKE FORESTMatthew E.  MonaghanDirector ELYRIADavid Y  NortonDirector EAST BRUNSWICKDavid Y  NortonRALEIGHJames T.  OgleDirector RALEIGHTEACHERS PENSION PLAN BOARD  ONTARIODirector TORONTOTEACHERS PENSION PLAN BOARD  ONTARIO10% Owner TORONTOEric  PaquesDirector RALEIGHGregory S  RushExecutive VP and CFO CALABASASGregory S  RushRALEIGHTerry  WoodwardRALEIGHPersons related to Charles C  Harwood Jr - Avista Healthcare Public Acquisition Corp.NamePositionCityAvista Acquisition Corp. NEW YORKAvista Acquisition, LLCNEW YORKHakan  Bjorklund WALTHAMDavid F  BurgstahlerNEW YORKJohn  CafassoNEW YORKThompson  DeanRADNORCharles C  Harwood Jr RALEIGHBRIAN A  MARKISON BRISTOLRobert P  O'Neil NEW YORKBenjamin  SilbertNEW YORK












 






Charles C. Harwood, Jr., Joins Cellectar, Inc.'s Board of... (     MADISON Wis. Sept. 18 /- Cellecta...)HomeBiologyMedicineTechnologyProductsNewsDefinitionDictionaryMoviesLinksSearchRSSNavigation LinksBiology NewsMedicine NewsBiology ProductsMedicine ProductsBiology DefinitionMedicine DefinitionBiology TechnologyMedicine TechnologyBiology DictionaryMedicine DictionaryHOME >> BIOLOGY >> TECHNOLOGYCharles C. Harwood, Jr., Joins Cellectar, Inc.'s Board of Directors...    MADISON Wis. Sept. 18 /- Cellectar Inc. aprivate...Mr. Harwood 55 is a Healthcare Industry Advisor for Avista CapitalP... Charlie brings exceptional financial and transaction expertise to the...Mr. Harwood also serves on the Board of Directors at BioReliance Inc.... http://www.bio-medicine.org/inc/biomed/biology-technology.asp http://feeds.bio-medicine.org/latest-biology-technologyDate:9/18/2008   

    MADISON, Wis., Sept. 18 /PRNewswire/ -- Cellectar, Inc., a
privately-held radiopharmaceuticals company that designs and develops
products to detect, treat and monitor human cancers, today announced the
appointment of Charles C. Harwood, Jr., to the Company's Board of
Directors.
Mr. Harwood, 55, is a Healthcare Industry Advisor for Avista Capital
Partners, a NYC-based private equity firm. Prior to working with Avista,
Mr. Harwood was President and Chief Executive Officer of privately-held
Focus Diagnostics, Inc. from 2002 until the company's sale in 2006. With
more than 20 years of experience in the healthcare industry, he has also
served as Senior Vice President and Chief Financial Officer of Covance,
Inc., one of world's largest drug development service companies.
"Charlie brings exceptional financial and transaction expertise to the
Cellectar Board," commented William Clarke, MD, M.Sc, President and CEO of
Cellectar. "His years of experience in the drug development industry will
prove beneficial to the Company as we advance our radiopharmaceutical
products toward clinical testing and commercialization."
Mr. Harwood also serves on the Board of Directors at BioReliance, Inc.,
a contract research organization specializing in biological safety testing
and specialized toxicology, RadPharm, Inc., a privately-held contract
research organization located in Princeton, NJ, and Itero
Biopharmaceuticals, Inc., a development stage company located in the San
Francisco Bay Area.
About Cellectar
Cellectar, Inc. is a radiopharmaceutical company that designs, develops
and manufactures products to detect, treat and monitor a wide variety of
human cancers. Cellectar's novel product candidates combine lipid-like
molecules, phospholipid ethers (PLEs) analogs, with radioisotopes that can
either image or destroy malignant cells. Cellectar's products' unique
mechanism of action is based on their accumulation and selective retention
in malignant tumors and not in normal cells. The Company's operations are
based in Madison, WI. Cellectar has previously raised approximately $22.0
million from angel and venture capital investors; including Continuum
Investment Partners and Venture Investors, LLC. For further information
about Cellectar, visit the Company's website at http://www.cellectar.com.


'/>"/>SOURCE Cellectar, Inc.Copyright©2008 PR Newswire.All rights reserved0GOODRelated biology technology :1. Ocular Biopharmaceutical Company Charlesson Announces $1.6MM in New Funding and Upcoming Presentations at The Association for Research in Vision and Ophthalmology2. DaVita Announces Retirement of Former Chief Medical Officer Charles J. McAllister, M.D.3. Dr. Charles A. Sims of California Cryobanks Family Cord Blood Services Named to National Stem Cell Advisory Council4. PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities5. Informed Medical Communications Appoints Charles T. Saldarini to Board of Directors6. Industry Pioneer Joins Profectus BioSciences to Support Innovation in Therapeutic and Preventative Vaccines7. David Hsia, Ph.D. Joins Kinex Pharmaceuticals Board of Directors8. Dr. Paul Korner Joins Ferring Pharmaceuticals as Vice President, Medical Affairs9. The National Cancer Institute Joins the Global Community of Scientists Now Using BIOMARKERcenter From Thomson Reuters10. GM Exec Joins Bio-Reaction Industries Board of Directors11. Nicholas J. Hart Joins Emisphere as Vice President, Strategy and Development

Post Your Comments: *Name:*Comment: *Email: 
(Date:7/26/2017)... Biosciences Inc., a world leading specialty CRO announced the publication ... early stage (latent) Mycobacterium tuberculosis (Mtb) infection using state-of-the-art ProteoCarta™, ...           ...  Caprion Biosciences Inc. (CNW Group/Caprion Biosciences)    ...   The new data, recently published in  EbioMedicine ... (Date:7/26/2017)...               ...               ...   Proscia Inc. , a software solutions provider for digital pathology, announced today ... His talk, “The Davids vs. the Cancer Goliath,” will discuss how Proscia and other ... Data) sectors are taking aim at cancer diagnosis and research. Proscia will also be ... (Date:7/26/2017)...              ...    July 25, 2017 ,       ...            In this ... better understanding of the considerations needed for designing ideal guide RNAs and DNA ... CRISPR-Cas9 to create targeted double-strand breaks in genomic DNA has greatly simplified strategies ... (Date:7/26/2017)...              ... 2017 ,            ...       Spectral imaging is a non-destructive technique used ... unique capability combines high resolution imaging with spectral analysis.  The system is ... chemical analysis, quality control, and decision-making. , Snapshot spectral imaging is key for ... Breaking Biology Technology:[0] Caprion Biosciences Expands Biomarker Panel Portfolio to Include Predictive Tuberculosis (TB) Infections[0] Proscia Takes Aim at Cancer with Artificial Intelligence and Digital Pathology Software[0] GE Healthcare Offers a Virtual Workshop for Precise HDR-mediated Genome Engineering[0] Sign up for Hyperspectral Imaging Demos Commencing in August(Date:4/13/2017)...  , April 13, 2017    According to a ... Identity Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment ... the IAM Market is expected to grow from USD 14.30 Billion in ... Rate (CAGR) of 17.3%.         ...           MarketsandMarkets Logo ... (Date:4/11/2017)... --   NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" ... of independent Directors Mr.  Robin D. Richards  and ... furthering the company,s corporate governance and expertise.    ...     Gino Pereira , Chief Executive Officer ... guidance and benefiting from their considerable expertise as we move ... (Date:4/5/2017)...  KEY FINDINGS   The global market ... CAGR of 25.76% during the forecast period of 2017-2025. ... for the growth of the stem cell market.  ... MARKET INSIGHTS The global stem cell market is segmented ... The stem cell market of the product is segmented ... Breaking Biology News(10 mins):[0] Consumer IAM Market Worth 31.75 Billion USD by 2022[0] NXT-ID Inc. Announces Appointment of Two New Independent Directors to Board[0] GLOBAL STEM CELL MARKET FORECAST 2017-2025Biology NavigationAIDS/HIVBioinformaticsBiotechnologyBiochemistryCancerCell BiologyDevelopmental BiologyEcologyEnvironmentEvolutionFood TechnologyGeneGeneticsGenomicsHealth/MedicineImmunologyMicroarrayMicrobiologyMolecularMarine BiologyNanobiotechnologyNeurobiologyPlant SciencesStem CellSystems BiologyVirusWomen HealthMedical NavigationAbortionAchesADHDAddictionAlcoholAllergyAlternative MedicineAlzheimer's DementiaAnxiety/StressArthritisAutismBacteriaBloodBird Flu/Avian FluBonesBreast CancerCancerCardiovascularCervical CancerChikungunyaCholesterolClinical TrialsColorectal CancerConferencesCrohn'sCystic FibrosisDengueDentistryDepressionDiabetesDrugEating DisordersEducationEpilepsyErectile DysfunctionEye Health/BlindnessFertilityFlu/ColdGastroIntestinalGeneticsGoutHeadache/MigraineHearing/DeafnessHIV/AIDSHuntington's DiseaseHypertensionImmune System/VaccinesInsuranceInfectious DiseasesIrritable-Bowel SyndromeInternetLeukemiaLifestyleLiver Disease/HepatitisLung CancerLupusMad Cow DiseaseMedical DevicesMedical Students/TrainingMedicare/MedicaidMedicoMen's healthMental HealthMRI/UltrasoundMRSA/Drug ResistanceMultiple SclerosisMuscular DystrophyNeurologyNursingNutrition/DietObesity/Weight LossPain/AnestheticsParkinson's DiseasePediatrics/Children's HealthPharma/Biotech IndustryPharmacy/PharmacistsPregnancyPrematureProstatePsychology/PsychiatryRehabilitationRespiratory/AsthmaSARSSchizophreniaSeniors/AgingSexual HealthSleep/Sleep DisordersSmokingStatinsStem Cell ResearchStrokeSurgeryTransplants/Organ DonationsVirusesWater - Air QualityWomen's HealthCopyright © 2003-2012 Bio-Medicine.  All rights reserved.ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS







Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft











	Charles C Harwood Jr Joins Cellectar Inc s Board of Directors













































Employer:
Login
Post Jobs


Job Seeker:
Login
Sign Up

























Search Life Sciences Jobs





Search Job Title Only












Radius:
Miles



Km80.5
















                 News | News By Subject | News by Disease |  
    News By Date | Search News



















Get Our FREEIndustry eNewsletter

email:


*
            
*
            



















 

 






Charles C. Harwood, Jr., Joins Cellectar, Inc.'s Board of Directors  











Tweet








9/18/2008 10:21:24 AM


MADISON, Wis., Sept. 18 /PRNewswire/ -- Cellectar, Inc., a privately-held radiopharmaceuticals company that designs and develops products to detect, treat and monitor human cancers, today announced the appointment of Charles C. Harwood, Jr., to the Company's Board of Directors. Mr. Harwood, 55, is a Healthcare Industry Advisor for Avista Capital Partners, a NYC-based private equity firm. Prior to working with Avista, Mr. Harwood was President and Chief Executive Officer of privately-held Focus Diagnostics, Inc. from 2002 until the company's sale in 2006. With more than 20 years of experience in the healthcare industry, he has also served as Senior Vice President and Chief Financial Officer of Covance, Inc., one of world's largest drug development service companies. "Charlie brings exceptional financial and transaction expertise to the Cellectar Board," commented William Clarke, MD, M.Sc, President and CEO of Cellectar. "His years of experience in the drug development industry will prove beneficial to the Company as we advance our radiopharmaceutical products toward clinical testing and commercialization."Mr. Harwood also serves on the Board of Directors at BioReliance, Inc., a contract research organization specializing in biological safety testing and specialized toxicology, RadPharm, Inc., a privately-held contract research organization located in Princeton, NJ, and Itero Biopharmaceuticals, Inc., a development stage company located in the San Francisco Bay Area.About CellectarCellectar, Inc. is a radiopharmaceutical company that designs, develops and manufactures products to detect, treat and monitor a wide variety of human cancers. Cellectar's novel product candidates combine lipid-like molecules, phospholipid ethers (PLEs) analogs, with radioisotopes that can either image or destroy malignant cells.  Cellectar's products' unique mechanism of action is based on their accumulation and selective retention in malignant tumors and not in normal cells. The Company's operations are based in Madison, WI.  Cellectar has previously raised approximately $22.0 million from angel and venture capital investors; including Continuum Investment Partners and Venture Investors, LLC. For further information about Cellectar, visit the Company's website at www.cellectar.com.CONTACT:  Investors: John Capodanno, Tel: +1-212-850-5705,john.capodanno@fd.com, or Media: Irma Gomez-Dib, Tel: +1-212-850-5761,irma.gomez-dib@fd.com, both of FD Life Sciences, for Cellectar, Inc. Web site:  http://www.cellectar.com/ 






                Read at
                BioSpace.com







Related News
Cellectar, Inc. Begins GMP Production Radiopharmaceutical Production Facility to Support Clinical Development for Lead Drug Candidate and Other Molecules  From Xbox To T-Cells: Michigan Tech Researchers Borrow Video Game Technology To Model Human Biology  Cellectar, Inc. Raises $13 Million in Private Offering  Siemens Healthcare Diagnostics to Create 80 Jobs in Indiana  Cellectar LLC Expands Clinical Management Team  ArKal Medical, Inc. Secures $17.5 Million in Series B Financing  Invitrogen Corporation (IVGN) and Applied Biosystems (ABI) Announce Divisional Structure and Executive Leadership Team  New Tool For Early Diagnosis Of Breast Cancer, University of Helsinki, European Molecular Biology Laboratory, Turku University Central Hospital, University Hospital of Grenoble Study  Colon X-Ray Seen As Effective At Spotting Cancer; Virtual Colonoscopy Gets An Endorsement, National Cancer Institute Study  Seeing Through The Skin: Optic-less Imaging Technology Could Beat Lens-based Imaging Devices, Tel Aviv University Study  




Please enable JavaScript to view the comments powered by Disqus.
comments powered by Disqus






















                            •
                            BioSpace.com










                            •
                            Cellectar, Inc.




             
        





                            •
                            Diagnostics



                            •
                            Medical Dev. & Diag. - Earnings




             
        















                              
                            

                              
                             
                              
                            

                              
                            








                 































Charles C. Harwood Jr.: Executive Profile & Biography - Bloomberg









































  





















































































July 28, 2017 11:12 PM ET
Capital Markets

Company Overview of Avista Capital Holdings, L.P.



SnapshotPeople 




OverviewBoard MembersCommittees



Executive Profile
Charles C. Harwood Jr.Operating Executive, Avista Capital Holdings, L.P.AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 7 different industries.See Board Relationships64--
Background

		Mr. Charles C. Harwood, Jr., is an Operating Executive at Avista Capital Holdings, L.P. Mr. Harwood is an Industry Advisor to Avista. He was retained by Avista Capital Partners in 2007. He worked with the Avista healthcare team that purchased BioReliance in 2007. He served as Chief Executive Officer and President of BioReliance Corporation Since April 2009 until March 2013. Mr. Harwood served as Executive Chairman at BioReliance Corporation from February 14, 2007 to ... December 3, 2007 and served as Interim Chief Executive Officer from October 2007 to December 3, 2007. He led BioReliance for over a year under Sigma-Aldrich ownership to provide a smooth transition of leadership. He served as the President and Chief Executive Officer at Focus Diagnostics Inc. since July, 2002 until July 2006. He has been Director at Avista Healthcare Public Acquisition Corp. since October 16, 2016. He was its Director Previously, from 1993 to 2001, Mr. Harwood held several positions, including the Chief Financial Officer and Senior Vice President of Venture Development at Covance, Inc., where he spearheaded numerous acquisitions and divestitures as well as the spin-off of Covance from Corning. From May 1993 to November 1994, he was an Executive Director of Finance of Covance. He was employed at HP Inc. From January 1993 to May 1993, Mr. Harwood was the Chief Financial Officer and Vice President of Finance at Integrated Telecom Technologies, Inc. Prior to Covance, he worked for seven years in commercial real estate development and six years in the medical products division at the Hewlett-Packard Company. He serves as the Chairman of ACP Mountain Holdings. He served as an Independent Director at INC Research Holdings, Inc. from September 2010 to November 4, 2016. Mr. Harwood served as an Independent Director of Itero Biopharmaceuticals, LLC. He served as Director of BioReliance Corporation, BioReliance Holdings, Inc. and Focus Diagnostics, Inc. He served on the Board of CoreLab Partners, Inc. He served as a Director of Cellectar Biosciences, Inc. since September 2008. Mr. Harwood has over 30 years of experience in healthcare and business. He was a proven operator in the clinical diagnostics and pharmaceutical services industries. Mr. Harwood received an M.B.A. from Harvard Business School at Harvard University in 1979 and a B.A. in Economics from Stanford University in 1975.Read Full Background




Corporate Headquarters
65 East 55th StreetNew York, New York 10022United StatesPhone: 212-593-6900Fax: 212-593-6901
Board Members Memberships
2016-PresentDirectorAvista Healthcare Public Acquisition Corp.
Education
BA 1975Stanford UniversityMBA 1979Harvard Business School
Other Affiliations
HP Inc.Stanford UniversityCovance Inc.BioReliance CorporationDiasorin Molecular LLCHarvard Business SchoolCoreLab Partners, Inc.Cellectar Biosciences, Inc.Itero Biopharmaceuticals, Inc.INC Research Holdings, Inc.Avista Healthcare Public Acquisition Corp.


Annual Compensation
				There is no Annual Compensation data available.
				Stocks Options
				There is no Stock Options data available.
				Total Compensation
				There is no Total Compensation data available.
			



Request Profile Update
















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



COMPETITOR COMPENSATIONThere is no Competitor Compensation data available.










Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Avista Capital Holdings, L.P., please visit .  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close



























Charles C. "Charlie" Harwood , Jr., Avista Capital Holdings, LP [Avista Capital Partners] - Leadership® Profile

































Products


Resources


About 


Client Support


Order








Leadership® ProfileLast changed: 7/24/2017  
Charles C. "Charlie" Harwood , Jr. 
Industry ExecutiveAvista Capital Holdings, LP [Avista Capital Partners]
Telephone, Address, and Education History available

Total Positions available: 1

Career History includes:
President and Chief Executive Officer,  , BioReliance Corporation , (2009-2013) 
(1 additional careers available)


 Purchase This Profile
Request Free Trial


Subscribe to one of these Leadership® Online products for unlimited access:
Leadership Networks® The Leadership Library®


About Leadership Directories, Inc. [LDI]

	Leadership Directories, Inc. [LDI] is a B2B information services company which provides premium content and contact solutions. LDI researches and publishes verified profiles of influential people and organizations from the federal government, state and local governments, public and private companies, law firms and courts, media outlets, healthcare organizations, nonprofits and associations, and the U.S. Congress.LDI's unique database of 900,000 contacts and 165,000 organizations is available online, in print, and as custom data services. Our high-quality data is updated daily with 4,000+ changes verified by NYC- and DC-based staff.


 




                Toll free: 1-800-627-0311

                1407 Broadway, Suite 318, New York, NY 10018
Tel: (212) 627-4140     Fax: (212) 645-0931
            

                1667 K Street, NW, Suite 801, Washington, DC 20006
Tel: (202) 347-7757       Fax:
                (202) 628-3430
            




Terms of use

|

Privacy Policy

|

FAQ

|

Contact us


 ©  Leadership Directories, Inc.
            









Charles Harwood in CA - Found at 30 Locations | BeenVerified





































All States
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District Of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming






Search













BeenVerified

 > 

People White Pages

 > 

Harrison to Hawkins

 > 

Harwood to Harwood

 > 

Charles Harwood

 > 

Charles Harwood in CA

 


8 results found for Charles Harwood in California
Search public records for Charles Harwood




FILTER BY STATE

All Current
Arizona (1)
Arkansas (1)
California (5)
Idaho (1)
Any State



FILTER BY AGE

All Ages
41-60 (1)
61-80 (3)
81+ (4)














Charles A Harwood


 Age: 53




City: Coeur D Alene
State: Idaho





View Profile Now





 Relatives: Diana M Harwood, Virginia N Harwood, Virginia N Harwood


 Addresses: 706 W Davidson Ave, Coeur D Alene, ID; 707 N 12th St, Coeur D Alene, ID; 122 E Borah Ave Apt 2, Coeur D Alene, ID


 Previous Locations: Kellogg, ID; Ventura, CA

View Profile Now









Charles C Harwood


 Age: 89




City: Portola Valley
State: California





View Profile Now





 Relatives: Katharine C Thompson, Charles C Harwood, Charles C Harwood


 Phone Number: 650-529-9371


 Addresses: 89 Palmer Ln, Portola Valley, CA; 420 Cervantes Rd, Portola Valley, CA; 

View Profile Now









Charles D Harwood


 Age: 62




City: Anaheim
State: California





View Profile Now





 Relatives: Charles W Harwood, Thos Harwood, Thos Harwood


 Phone Number: 714-595-5127


 Addresses: 2550 E Ward Ter Apt 56, Anaheim, CA; 535 Slope Dr, Walnut, CA; 6707 W Wanda Lynn Ln, Peoria, AZ


 Previous Locations: Fullerton, CA; Glendale, AZ; La Habra, CA

View Profile Now









Charles E Harwood


 Age: 87




City: Hereford
State: Arizona





View Profile Now





 Addresses: 6102 E Star Ln, Hereford, AZ; 1869 Atwater Blvd, Atwater, CA; Po Box 307, Hereford, AZ


 Previous Locations: Ceres, CA; Tucson, AZ

View Profile Now









Charles F Harwood


 Age: 84




City: Fresno
State: California





View Profile Now





 Relatives: Stephaine Deforest


 Addresses: 970 E Spruce Ave, Fresno, CA; 3550 N Duke Ave Spc 27, Fresno, CA; 1944 W Ashlan Ave, Fresno, CA

View Profile Now









Charles G Harwood


 Age: 63




City: Perryville
State: Arkansas





View Profile Now





 Relatives: Renei L Harwood, Kelly R Harwood


 Phone Number: 501-333-2681


 Seen As: Charles G Harwood Ii


 Addresses: 46500 S Highway 10, Perryville, AR; 6168 W Megan St, Chandler, AZ; 116 Noyant Dr, Little Rock, AR


 Previous Locations: Davis, CA; Lexington, KY

View Profile Now









Charles W Harwood


 Age: 73




City: Ventura
State: California





View Profile Now





 Relatives: Timothy E Harwood, Johnathan A Harwood, Johnathan A Harwood


 Phone Number: 573-635-4607


 Email: whit****@cnmnetwo.com


 Seen As: Charles W Harwood Jr


 Addresses: 935 Jonquill Ave, Ventura, CA; 4011 Buckingham Park, Jefferson City, MO; 1071 Britten Ln Apt 208, Ventura, CA


 Previous Locations: Camarillo, CA; Herlong, CA; Fillmore, CA; Oxnard, CA

View Profile Now









Charles W Harwood


 Age: 82




City: Diamond Bar
State: California





View Profile Now





 Relatives: Charles D Harwood, Thos Harwood


 Phone Number: 714-595-5127


 Addresses: 314 S Prospectors Rd Unit 17, Diamond Bar, CA; 535 Slope Dr, Walnut, CA; 1750 Tuffree Blvd, Placentia, CA


 Previous Locations: La Habra, CA

View Profile Now












Public Records Available for Charles Harwood 


See Full Report










Court Records
Get Report







Social Accounts
Get Report







Education History
Get Report







Professional History
Get Report











We found records for other Harwood's





Diana Harwood
 Get Report


Renei Harwood
 Get Report


Charles Harwood
 Get Report


Timothy Harwood
 Get Report










Contact Information Available






NAME
AGE
ZIP




Charles Harwood

                      62                    

                      92806                    

Search Info



Charles Harwood

                      53                    

                      83814                    

Search Info



Charles Harwood

                      87                    

                      85615                    

Search Info



Charles Harwood

                      63                    

                      72126                    

Search Info














Filter by Age







41-60 (1)
61-80 (3)
81+ (4)







Filter by City





Anaheim, CA (1)
Atwater, CA (1)
Camarillo, CA (1)
Ceres, CA (1)
Davis, CA (1)
Diamond Bar, CA (1)
Fillmore, CA (1)
Fresno, CA (1)
Fullerton, CA (1)
Herlong, CA (1)
La Habra, CA (2)
Oxnard, CA (1)
Placentia, CA (1)
Portola Valley, CA (1)
Ventura, CA (2)
Walnut, CA (2)
 Show More







Filter by Current State





 All States
Arizona (1)
Arkansas (1)
California (5)
Idaho (1)














Not the Charles Harwood you are looking for?
Search Public Records
This search may reveal criminal records, bankruptcies, photos and more!







Search Any Name for Free!
Billions of records at your fingertips. Just download our app.










Searching for yourself?
Find out what information we have on you!



Search Now!


















Stock Screener - Yahoo FinanceHomeMailFlickrTumblrNewsSportsFinanceCelebrityAnswersGroupsMobileMoreYahooSearchSearch0U.S. Markets closedS&P 5002,472.10-3.32 (-0.13%)Dow 3021,830.31+33.76 (+0.15%)LISTENWho is the face of pro baseball?Yahoo Finance's Dan Roberts and Myles Udland debate the business of baseballInsider TransactionsDefault CriteriaInsider & Restricted Shareholder Transactions1-2 of 2 resultsResults were generated a few mins ago. Pricing data is updated frequently. Currency in USDSymbolDateSharesProceedsTransaction DetailsINCR2016-08-238,753N/AAcquisition (Non Open Market)INCR2016-05-232,231N/AAcquisition (Non Open Market) at $0.00 per share.The 'two pizza rule' is a secret to productive meetings that helped Amazon CEO Jeff Bezos become one of the world's richest menBusiness InsiderThis Will Be In Everyone's Household By 2020Banyan HillSponsoredHere are the US targets North Korea most likely wants to nukeBusiness InsiderYahoo Small BusinessData DisclaimerHelpSuggestionsPrivacyAbout Our AdsTerms (Updated)





